Bridging Echinocandin With Azole Antifungal Therapy on Prevention of Invasive Candidiasis Post–Lung Transplantation
In combination with an azole antifungal, micafungin did not prevent IC in postoperative LTRs with cultures positive for <i>Candida</i> species in this cohort. Larger prospective studies are needed to determine the ideal combination and duration of antifungal prophylaxis.
Authors
- T. Pasley (ORCID: https://orcid.org/0000-0002-7536-3899)
- Maureen Converse
- Guy El Helou (ORCID: https://orcid.org/0000-0001-8787-5624)
- Eric Rubido
- Kathryn DeSear (ORCID: https://orcid.org/0000-0002-9042-9075)
- Solmaz Karimi (ORCID: https://orcid.org/0009-0008-0179-0899)
- Christopher B Baladad (ORCID: https://orcid.org/0000-0001-8067-1493)
Institutions
- Cleveland Clinic (US)
- UF Health Shands Hospital (US)
- Pomerado Hospital (US)
- University of Florida Health (US)
- The Ohio State University Wexner Medical Center (US)
- University of Florida (US)
- Methodist Hospital (US)
- University of Florida Health Science Center (US)
Publication Details
- Journal
- Open Forum Infectious Diseases
- Published
- 2024-08-30
- DOI
- https://doi.org/10.1093/ofid/ofae525
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 0.00